Ownership history in EDGEWOOD MANAGEMENT LLC · 81 quarters on record
This page tracks every 13F SEC filing in which EDGEWOOD MANAGEMENT LLC reported a position in VERTEX PHARMACEUTICAL COMMON (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,060,075 | -427,467 | -28.7% | 2.29% | $480.6M | $453.36 |
| 2025 Q3 | REDUCED | 1,487,542 | -967,405 | -39.4% | 2.06% | $582.6M | $391.64 |
| 2025 Q2 | REDUCED | 2,454,947 | -189,079 | -7.2% | 3.47% | $1.09B | $445.20 |
| 2025 Q1 | REDUCED | 2,644,026 | -312,582 | -10.6% | 4.46% | $1.28B | $484.82 |
| 2024 Q4 | ADDED | 2,956,608 | +1,410,238 | +91.2% | 3.42% | $1.19B | $402.70 |
| 2024 Q3 | ADDED | 1,546,370 | +1,526,983 | +7876.3% | 1.94% | $719.2M | $465.08 |
| 2024 Q2 | UNCHANGED | 19,387 | — | 0% | 0.02% | $9.1M | $468.72 |
| 2024 Q1 | REDUCED | 19,387 | -1,063 | -5.2% | 0.02% | $8.1M | $418.01 |
| 2023 Q4 | UNCHANGED | 20,450 | — | 0% | 0.02% | $8.3M | $406.89 |
| 2023 Q3 | UNCHANGED | 20,450 | — | 0% | 0.02% | $7.1M | $347.74 |
As of 2025 Q4 — sorted by position size